FDA Approves Radioembolization Therapy for Liver Cancer
Y-90 microspheres achieved 98.5% response rate and 100% local tumor control in unresectable HCC patients across multicenter trial.
Hepatocellular Carcinoma
Latest Post
No posts found in this category.
